D-0642-2024 Class II Ongoing

Recalled by FDC Limited — Aurangabad, Maharashtra State

FDA drug recall D-0642-2024 was initiated by FDC Limited on Aug 12, 2024 and is designated Class II. Reason for recall: Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle. The recall status is ongoing. Affected quantity: 176,784 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 28, 2024
Initiation Date
Aug 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
176,784 bottles

Product description

Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

Reason for recall

Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Distribution pattern

Nationwide U.S.A.

Code information

Lot #: a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0642-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0642-2024. Report a data issue: hello@regdatalab.com.